[ORGANIZATION]
Alteogen
Featured in 8 tracked stories · first seen
Situations
Keytruda therapeutic expansions and approvals
2 clusters · 24 sources · last updated
Latest: European Commission approves bladder cancer treatment
The immunotherapy drug Keytruda has seen recent developments regarding new formulations and expanded clinical applications. In South Korea, MSD Korea announced the October launch of a subcutaneous (SC) formulation of Ke
Daejeon municipal administration under Mayor Heo Tae-jeong
2 clusters · 4 sources · last updated
Latest: Daejeon Mayor Heo Tae-jeong outlines 100-day priorities
Daejeon Mayor Heo Tae-jeong initially presented a vision for his 9th civil election term, focusing on the city’s future direction and discussions regarding a special act for the administrative capital. Following his fir
Also covered in
-
Alteogen presents ADC subcutaneous injection research at ESMO
[BUSINESS] · 3 sources ·
-
Dutch court blocks Merck's Keytruda SC in eight European markets
[BUSINESS] · 2 sources ·